In this study, the expression of FGFR3 in ESCC patients was significantly higher than that in tissues adjacent to carcinoma (64.5% (111/172)), which was consistent with FGFR3 expression in gastric and liver cancers in previous studies. The gene discussed is FGFR3; the disease is liver cancer.